The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solution USP, 0.1 per cent, Alembic Pharmaceuticals said in a filing to BSE.
from Industry-Economic Times https://ift.tt/2B56UwB
Post Top Ad
Monday, December 10, 2018
Alembic Pharmaceuticals gets USFDA nod for ophthalmic solution
Subscribe to:
Post Comments (Atom)
Post Top Ad
Responsive Ads Here
Author Details
Hinduism is a blogger resources site is a provider of high quality news. The main mission of Hinduism is to provide the best quality news which are professionally designed and perfectlly optimized to deliver best information.
No comments:
Post a Comment